Medindia

X

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

Friday, November 11, 2016 General News J E 4
Advertisement

NEW YORK, Nov. 10, 2016 /PRNewswire/ -- The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, and increase in adoption of protein based drugs over non-protein based drugs. In addition, rising opportunities in emerging markets, and top-selling biologics drugs going off-patent in the near future provides a growing opportunity to this market.

This report segments the global PEGylated proteins market by product, protein type, application and end-user. By product, the market includes consumables and services. Based on protein type, the market is segmented into colony stimulating factors, interferons, erythropoietin, mAbs, and recombinant factor VIII. The colony stimulating factors segment will hold the largest share of the PEGylated proteins type market in 2016. The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global the PEGylated proteins market in 2016. Asia is expected to register the fastest growth in the forecast period.

Research Coverage: This report studies the PEGylated proteins market based on product, protein type, application, and end-user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions

Reasons to Buy the Report: The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions. The report provides insights on the following:- Product Development/Innovation: Product portfolios of the top players in the PEGylated proteins market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the PEGylated proteins market- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various PEGylated proteins across geographies - Market Diversification: Exhaustive information about new products, recent developments, and investments in the PEGylated proteins marketRead the full report: http://www.reportlinker.com/p04298853-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pegylated-proteins-market-by-consumables-services-protein-type-application-end-user---global-forecast-to-2021-300361151.html

SOURCE Reportlinker

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
EU5 Multiparameter Patient Monitoring Market Outlo...
S
SneakGuard™ One of Twelve Startups to Pitch to Top...